Russian diplomat: No message received from Washington on its participation in Astana talksRussian Politics & Diplomacy January 19, 17:08
Results of Siberian Craton research to be used in discovering new diamond depositsBusiness & Economy January 19, 16:36
Diplomat says Moscow expects new Syrian groups to join ceasefire at Astana talksRussian Politics & Diplomacy January 19, 16:23
Ankara vows to leave no stone unturned in Russian envoy's murder investigationWorld January 19, 16:10
Diplomat: Trump’s inauguration raises hope for end of crisis in Russia-US relationsRussian Politics & Diplomacy January 19, 16:06
Russian diplomat believes Astana meeting on Syria to strengthen ceasefire regimeRussian Politics & Diplomacy January 19, 16:00
US embassy in Russia passes to Washington invitations to Astana talks on SyriaWorld January 19, 15:39
Ankara hopes for success of Syrian talks in Astana — Turkey’s deputy PMWorld January 19, 15:35
Russia’s St. Petersburg unveils its official logo for 2020 UEFA Euro CupSport January 19, 14:47
ATLANTA and STOCKHOLM, Feb. 4, 2013 /PRNewswire/ -- At an exclusive event scheduled March 1, 2013, Elekta will reveal a leap forward in radiation oncology and the care of individuals with cancer worldwide.
Founded in 1972, Elekta was the first to bring a completely digital linear accelerator to the market, as well as the first to fully integrate imaging technology in the treatment system. Elekta is a market-leading developer of cancer care and neuroscience solutions, including a world-class portfolio of linear accelerators, dedicated radiosurgery and brachytherapy systems and oncology information and treatment planning software solutions.
"At Elekta, we are united by a passion that drives us to constantly strive toward the development of new cancer care solutions that benefit patients, caregivers and healthcare systems," says Elekta's President and CEO Tomas Puusepp. "It is this unrelenting dedication to patients and their healthcare providers that has inspired our efforts to create a truly singular technological solution in radiation oncology."
The worldwide unveiling event will be held Friday, March 1 at the Renaissance Atlanta Waverly Hotel, Atlanta, Georgia, USA, 11 a.m. - 12 p.m. EST. To attend or view live online, register at www.elekta.com.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.